PAPER Sala Frigerio C, Fadeeva JV, Minogue AM, Citron M, Van Leuven F, Staufenbiel M, Paganetti P, Selkoe DJ, Walsh DM
SEARCH RESULTS
330986 RESULTS
PAPER Hernandez CM, Kayed R, Zheng H, Sweatt JD, Dineley KT
Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
J Neurosci. 2010 Feb 17;30(7):2442-53. PubMed: 20164328PAPER Jauhar S, Pelosi A
New Alzheimer's disease screening test performs well in UK outpatient settings.
Evid Based Ment Health. 2010 Feb;13(1):11. PubMed: 20164508PAPER Aisa B, Gil-Bea FJ, Solas M, García-Alloza M, Chen CP, Lai MK, Francis PT, Ramírez MJ
Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.
J Alzheimers Dis. 2010;20(2):659-68. PubMed: 20164549PAPER García AM, Ramón-Bou N, Porta M
Isolated and joint effects of tobacco and alcohol consumption on risk of Alzheimer's disease.
J Alzheimers Dis. 2010;20(2):577-86. PubMed: 20164550PAPER Head E, Pop V, Sarsoza F, Kayed R, Beckett TL, Studzinski CM, Tomic JL, Glabe CG, Murphy MP
Amyloid-beta peptide and oligomers in the brain and cerebrospinal fluid of aged canines.
J Alzheimers Dis. 2010;20(2):637-46. PubMed: 20164551PAPER Chen TF, Huang RF, Lin SE, Lu JF, Tang MC, Chiu MJ
Folic Acid potentiates the effect of memantine on spatial learning and neuronal protection in an Alzheimer's disease transgenic model.
J Alzheimers Dis. 2010;20(2):607-15. PubMed: 20164552PAPER Söderqvist F, Hardell L, Carlberg M, Mild KH
Radiofrequency fields, transthyretin, and Alzheimer's disease.
J Alzheimers Dis. 2010;20(2):599-606. PubMed: 20164553PAPER Bastin C, Kerrouche N, Lekeu F, Adam S, Guillaume B, Lemaire C, Aerts J, d'Ydewalle G, Collette F, Salmon E
Controlled memory processes in questionable Alzheimer's disease: a view from neuroimaging research.
J Alzheimers Dis. 2010;20(2):547-60. PubMed: 20164554PAPER Lopez-Toledano MA, Ali Faghihi M, Patel NS, Wahlestedt C
Adult neurogenesis: a potential tool for early diagnosis in Alzheimer's disease?
J Alzheimers Dis. 2010;20(2):395-408. PubMed: 20164555PAPER Zhuo JM, Kruger WD, Praticò D
The Herp protein pathway is not involved in the pro-amyloidogenic effect of hyperhomocysteinemia.
J Alzheimers Dis. 2010;20(2):569-76. PubMed: 20164556PAPER Friese U, Meindl T, Herpertz SC, Reiser MF, Hampel H, Teipel SJ
Diagnostic utility of novel MRI-based biomarkers for Alzheimer's disease: diffusion tensor imaging and deformation-based morphometry.
J Alzheimers Dis. 2010;20(2):477-90. PubMed: 20164559PAPER Faux NG, Ritchie CW, Gunn A, Rembach A, Tsatsanis A, Bedo J, Harrison J, Lannfelt L, Blennow K, Zetterberg H, Ingelsson M, Masters CL, Tanzi RE, Cummings JL, Herd CM, Bush AI
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses.
J Alzheimers Dis. 2010;20(2):509-16. PubMed: 20164561PAPER Gahete MD, Rubio A, Durán-Prado M, Avila J, Luque RM, Castaño JP
Expression of Somatostatin, cortistatin, and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer's disease patients.
J Alzheimers Dis. 2010;20(2):465-75. PubMed: 20164562PAPER Li J, Zhang M, Xu ZQ, Gao CY, Fang CQ, Deng J, Yan JC, Wang YJ, Zhou HD
Vascular risk aggravates the progression of Alzheimer's disease in a Chinese cohort.
J Alzheimers Dis. 2010;20(2):491-500. PubMed: 20164563Current Filters
No filters selected